|
RSF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.94215999999026E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.03160000003633E-06 |
| Normal-vs-Stage2 |
1.882190E-02 |
| Normal-vs-Stage3 |
3.910200E-02 |
| Normal-vs-Stage4 |
3.042200E-02 |
| Stage1-vs-Stage2 |
7.257400E-01 |
| Stage1-vs-Stage3 |
3.990200E-01 |
| Stage1-vs-Stage4 |
8.191200E-01 |
| Stage2-vs-Stage3 |
7.482800E-01 |
| Stage2-vs-Stage4 |
6.581200E-01 |
| Stage3-vs-Stage4 |
4.989800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.16840000000418E-05 |
| Normal-vs-AfricanAmerican |
1.170130E-04 |
| Normal-vs-Asian |
4.413000E-04 |
| Caucasian-vs-AfricanAmerican |
6.717000E-01 |
| Caucasian-vs-Asian |
3.999800E-02 |
| AfricanAmerican-vs-Asian |
9.802400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.56669999488102E-08 |
| Normal-vs-Female |
5.776200E-01 |
| Male-vs-Female |
1.971080E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.799010E-03 |
| Normal-vs-Extreme_Weight |
1.08489999983696E-07 |
| Normal-vs-Obese |
2.278200E-02 |
| Normal-vs-Extreme_Obese |
6.04140000000086E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.810760E-01 |
| Normal_Weight-vs-Obese |
3.681400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.790200E-01 |
| Extreme_Weight-vs-Obese |
1.294070E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.238400E-01 |
| Obese-vs-Extreme_Obese |
1.265610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.931200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.718400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.86750000019664E-07 |
| Normal-vs-Age(81-100Yrs) |
2.20509999999674E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.575800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.169370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.098100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.669600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.426300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.704600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.01729999990985E-07 |
| Normal-VS-Type2 PRCC |
2.13540000004731E-06 |
| Normal-VS-KIRP CIMP |
1.932030E-01 |
| Normal-VS-Unclassified PRCC |
1.625980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.046400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.304000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.920300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.173600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.583800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.694100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69700000052231E-07 |
| Normal-vs-N1 |
7.543400E-01 |
| Normal-vs-N2 |
5.853400E-01 |
| N0-vs-N1 |
1.547810E-02 |
| N0-vs-N2 |
2.407200E-01 |
| N1-vs-N2 |
6.977600E-01 |
|
|
